Riazi-Esfahani M - Search Results

1

Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.

Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M. Ahmadieh H, et al. Retina. 2011 Oct;31(9):1819-26. doi: 10.1097/IAE.0b013e31820d58f2. Retina. 2011. PMID: 21555967 Clinical Trial.

2

Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Ahadi H. Ahmadieh H, et al. Eur J Ophthalmol. 2008 Mar-Apr;18(2):297-300. doi: 10.1177/112067210801800222. Eur J Ophthalmol. 2008. PMID: 18320527

3

Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial.

Piri N, Ahmadieh H, Taei R, Soheilian M, Karkhaneh R, Lashay A, Golbafian F, Yaseri M, Riazi-Esfahani M. Piri N, et al. J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):469-77. doi: 10.4103/2008-322X.150826. J Ophthalmic Vis Res. 2014. PMID: 25709773 Free PMC article.

4

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S. Ahmadieh H, et al. BMC Ophthalmol. 2007 Jun 7;7:10. doi: 10.1186/1471-2415-7-10. BMC Ophthalmol. 2007. PMID: 17555600 Free PMC article. Clinical Trial.

5

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration.

Riazi-Esfahani M, Ahmadieh H, Faghihi H, Piri N, Taei R, Karkhaneh R, Alami-Harandi Z, Lashay A, Mirshahi A, Nili-Ahmadabadi M, Soheilian M, Sanagou M. Riazi-Esfahani M, et al. J Ophthalmic Vis Res. 2008 Apr;3(2):95-101. J Ophthalmic Vis Res. 2008. PMID: 23479530 Free PMC article.

6

Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.

Riazi-Esfahani M, Riazi-Esfahani H, Ahmadraji A, Karkhaneh R, Mahmoudi A, Roohipoor R, Ghasemi F, Yaseri M. Riazi-Esfahani M, et al. Int Ophthalmol. 2018 Apr;38(2):585-598. doi: 10.1007/s10792-017-0496-4. Epub 2017 Mar 27. Int Ophthalmol. 2018. PMID: 28349504 Clinical Trial.

7

CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.

Roohipoor R, Sharifian E, Ghassemi F, Riazi-Esfahani M, Karkhaneh R, Fard MA, Zarei M, Modjtahedi BS, Moghimi S. Roohipoor R, et al. Retina. 2016 Oct;36(10):1997-2005. doi: 10.1097/IAE.0000000000001027. Retina. 2016. PMID: 27046456 Clinical Trial.

8

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.

Nikkhah H, Karimi S, Ahmadieh H, Azarmina M, Abrishami M, Ahoor H, Alizadeh Y, Behboudi H, Daftarian N, Dehghan MH, Entezari M, Farrahi F, Ghanbari H, Falavarjani KG, Javadi MA, Karkhaneh R, Moradian S, Manaviat MR, Mehryar M, Nourinia R, Parvaresh MM, Ramezani A, Haghi AR, Riazi-Esfahani M, Soheilian M, Shahsavari M, Shahriari HA, Rajavi Z, Safi S, Shirvani A, Rahmani S, Sabbaghi H, Pakbin M, Kheiri B, Ziaei H. Nikkhah H, et al. J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):158-169. doi: 10.4103/jovr.jovr_50_18. J Ophthalmic Vis Res. 2018. PMID: 29719645 Free PMC article.

9

Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab.

Ebrahimiadib N, Lashay A, Riazi-Esfahani H, Jamali S, Khodabandeh A, Zarei M, Roohipoor R, Khojasteh H, Bazvand F, Ojani M, Shahabinejad M, Yaseri M, Modjtahedi BS, Davoudi S, Riazi-Esfahani M. Ebrahimiadib N, et al. Among authors: riazi esfahani m. Ophthalmic Surg Lasers Imaging Retina. 2020 Mar 1;51(3):145-151. doi: 10.3928/23258160-20200228-03. Ophthalmic Surg Lasers Imaging Retina. 2020. PMID: 32211904

10

Comparison of Intravitreal Bevacizumab and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.

Roohipoor R, Karkhaneh R, Riazi-Esfahani M, Dastjani Farahani A, Khodabandeh A, Ebrahimi Adib N, Imani M, Khojasteh Jafari H, Riazi-Esfahani H, Hosseinpour J, Zarei M, Ghasemi H, Mirghorbani M, Yaseri M, Davoudi S, Modjtahedi BS. Roohipoor R, et al. Among authors: riazi esfahani m. Ophthalmol Retina. 2018 Sep;2(9):942-948. doi: 10.1016/j.oret.2018.01.017. Epub 2018 Mar 3. Ophthalmol Retina. 2018. PMID: 31047228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters